Closing the gap: Making high-dose flu vaccines accessible for seniors
Canada’s senior population is growing fast. According to Statistics Canada, by 2031 nearly one in four Canadians will be 65 or older. As we age,
Menu
One of CIAN‘s key priorities is to advocate for equitable access to vaccines and therapeutics, inclusive policies, and a safer environment for immunocompromised people to live and thrive. To advance these efforts, we have undertaken several letter-writing campaigns directed to key policymakers and stakeholders within the provincial and federal governments. By advancing these advocacy efforts with the united voice of our patient advocates and patient organizations, we ensure that Canada’s immunocompromised community is represented at decision-maker tables. Preview and download our recent letter writing campaigns below.
Canada’s senior population is growing fast. According to Statistics Canada, by 2031 nearly one in four Canadians will be 65 or older. As we age,
Our letter to the Ontario Government expresses concern in the recent announcement to halt provincial wastewater monitoring of COVID-19 and other infectious diseases.
Our letter on protein-based COVID-19 vaccine options covers critical topics like access issues, awareness gaps, communication barriers, and skepticism.
Our letter to NACI expresses gratitude for their recent guidance regarding the use of COVID-19 vaccines for Fall 2024.